Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.

Abstract

Apathy in the context of treated major depressive disorder (MDD) is a common but understudied symptom. This multicenter, double-blind, randomized study investigated whether switching from a selective serotonin reuptake inhibitor (SSRI) to a serotonin-norepinephrine reuptake inhibitor (SNRI), compared with switching to another SSRI, improved apathy symptoms… (More)
DOI: 10.1016/j.jpsychires.2012.02.010

Topics

Cite this paper

@article{Raskin2012ApathyIC, title={Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.}, author={Joel Raskin and Thomas R. George and Renee E. Granger and Nadia Hussain and George Zhao and Lauren B. Marangell}, journal={Journal of psychiatric research}, year={2012}, volume={46 5}, pages={667-74} }